DZ1850A1 - Formulation nouvelle comprenant un complexe de paroxétine et d'amberlite irp 88. - Google Patents
Formulation nouvelle comprenant un complexe de paroxétine et d'amberlite irp 88.Info
- Publication number
- DZ1850A1 DZ1850A1 DZ950010A DZ950010A DZ1850A1 DZ 1850 A1 DZ1850 A1 DZ 1850A1 DZ 950010 A DZ950010 A DZ 950010A DZ 950010 A DZ950010 A DZ 950010A DZ 1850 A1 DZ1850 A1 DZ 1850A1
- Authority
- DZ
- Algeria
- Prior art keywords
- paroxetine
- complex
- new formulation
- amberlite irp
- irp
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9402029A GB9402029D0 (en) | 1994-02-03 | 1994-02-03 | Novel formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DZ1850A1 true DZ1850A1 (fr) | 2002-02-17 |
Family
ID=10749765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DZ950010A DZ1850A1 (fr) | 1994-02-03 | 1995-02-01 | Formulation nouvelle comprenant un complexe de paroxétine et d'amberlite irp 88. |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US5811436A (fr) |
| EP (1) | EP0742715B1 (fr) |
| JP (1) | JP4445590B2 (fr) |
| CN (1) | CN1074922C (fr) |
| AP (2) | AP611A (fr) |
| AT (1) | ATE178489T1 (fr) |
| AU (1) | AU682091B2 (fr) |
| BG (1) | BG62843B1 (fr) |
| BR (1) | BR9507055A (fr) |
| CA (1) | CA2182593A1 (fr) |
| CZ (1) | CZ285128B6 (fr) |
| DE (1) | DE69508924T2 (fr) |
| DK (1) | DK0742715T3 (fr) |
| DZ (1) | DZ1850A1 (fr) |
| ES (1) | ES2129806T3 (fr) |
| FI (1) | FI118205B (fr) |
| GB (1) | GB9402029D0 (fr) |
| GR (1) | GR3030131T3 (fr) |
| HK (1) | HK1012288A1 (fr) |
| HU (1) | HUT75941A (fr) |
| IL (1) | IL112521A (fr) |
| MA (1) | MA23441A1 (fr) |
| MX (1) | MX9603203A (fr) |
| MY (1) | MY113036A (fr) |
| NO (1) | NO307954B1 (fr) |
| NZ (1) | NZ278891A (fr) |
| OA (1) | OA10446A (fr) |
| PL (1) | PL178331B1 (fr) |
| RO (1) | RO116342B1 (fr) |
| RU (1) | RU2136281C1 (fr) |
| SK (1) | SK281214B6 (fr) |
| TW (1) | TW436296B (fr) |
| WO (1) | WO1995020964A1 (fr) |
| ZA (1) | ZA95776B (fr) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6548084B2 (en) * | 1995-07-20 | 2003-04-15 | Smithkline Beecham Plc | Controlled release compositions |
| US6638948B1 (en) | 1996-09-09 | 2003-10-28 | Pentech Pharmaceuticals, Inc. | Amorphous paroxetine composition |
| DE29724281U1 (de) | 1997-06-10 | 2000-08-10 | Synthon Bv | 4-Phenylpiperidin-Verbindungen |
| US6699882B2 (en) | 1998-03-24 | 2004-03-02 | Smithkline Beecham P.L.C. | Paroxetine compositions |
| DK172860B1 (da) * | 1998-03-25 | 1999-08-16 | Pharmacosmos Holding As | Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman |
| CH689805A8 (fr) * | 1998-07-02 | 2000-02-29 | Smithkline Beecham Plc | Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant. |
| GB0003232D0 (en) * | 2000-02-11 | 2000-04-05 | Smithkline Beecham Plc | Novel composition |
| US6660298B1 (en) * | 2000-07-27 | 2003-12-09 | Pentech Pharmaceuticals, Inc. | Paroxetine tablets and capsules |
| US6720003B2 (en) * | 2001-02-16 | 2004-04-13 | Andrx Corporation | Serotonin reuptake inhibitor formulations |
| DE60232290D1 (de) * | 2001-04-09 | 2009-06-25 | Rohm & Haas | Kontrollierte Auflösung von Wirkstoffen |
| US20020176842A1 (en) * | 2001-04-09 | 2002-11-28 | Lyn Hughes | Extended release of active ingredients |
| US6906206B2 (en) * | 2001-04-30 | 2005-06-14 | Wyeth | Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene |
| GB0119467D0 (en) * | 2001-08-09 | 2001-10-03 | Smithkline Beecham Plc | Novel compound |
| WO2003013470A1 (fr) * | 2001-08-09 | 2003-02-20 | Smithkline Beecham Plc. | Composition comprenant de la paroxetine et un sel de glycyrrhizinate pharmaceutiquement acceptable |
| US6939877B2 (en) * | 2002-09-12 | 2005-09-06 | Wyeth | Antidepressant piperidine derivatives of heterocycle-fused benzodioxans |
| US20040220153A1 (en) * | 2002-09-24 | 2004-11-04 | Jost-Price Edward Roydon | Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
| US20050036977A1 (en) * | 2003-08-11 | 2005-02-17 | Dilip Gole | Taste-masked resinate and preparation thereof |
| US20050266082A1 (en) * | 2004-05-26 | 2005-12-01 | Patel Satishkumar A | Preparation of stable paroxetine HC1 ER tablets using a melt granulation process |
| US20060063737A1 (en) * | 2004-08-18 | 2006-03-23 | Holmdahl Lisa K | Liquid paroxetine compositions |
| WO2006023347A1 (fr) * | 2004-08-20 | 2006-03-02 | Alpharma, Inc. | Formulations à base de paroxétine |
| KR100672184B1 (ko) | 2004-09-21 | 2007-01-19 | 주식회사종근당 | 파록세틴의 콜린산 또는 콜린산 유도체 염 |
| US20070112031A1 (en) * | 2005-11-14 | 2007-05-17 | Gant Thomas G | Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties |
| CN102430122A (zh) * | 2005-12-13 | 2012-05-02 | 量子高科（北京）研究院有限公司 | 盐酸氟西汀口腔崩解片及其制备方法 |
| FR2912057B1 (fr) * | 2007-02-07 | 2009-04-17 | Sanofi Aventis Sa | Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine |
| TW200817003A (en) * | 2006-07-31 | 2008-04-16 | Sanofi Aventis | Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor |
| US20100273822A1 (en) * | 2009-04-22 | 2010-10-28 | William Wayne Howard | Immediate release compositions and methods for delivering drug formulations using strong acid ion exchange resins |
| BRPI1014756A2 (pt) * | 2009-06-25 | 2016-04-19 | Wockhardt Research Center | composição farmacêutica de duloxetina ou sais farmaceuticamente aceitáveis da mesma |
| US8187617B2 (en) * | 2009-09-11 | 2012-05-29 | William Wayne Howard | Immediate release compositions and methods for delivering drug formulations using weak acid ion exchange resins in abnormally high pH environments |
| BR112012029461A2 (pt) | 2010-05-19 | 2017-03-01 | Astellas Pharma Inc | composição farmacêutica contendo solifenacina |
| CN104027306A (zh) * | 2014-06-25 | 2014-09-10 | 万特制药(海南)有限公司 | 帕罗西汀口服混悬液及其制备方法 |
| GB201419261D0 (en) | 2014-10-29 | 2014-12-10 | Therakind Ltd | Formulations |
| CN104382870A (zh) * | 2014-10-30 | 2015-03-04 | 万全万特制药江苏有限公司 | 一种含有波拉克林钾-帕罗西汀的复合物 |
| CN106309363A (zh) * | 2016-09-24 | 2017-01-11 | 万特制药(海南)有限公司 | 盐酸帕罗西汀口服混悬液及其制备方法 |
| CN108926528A (zh) * | 2017-05-25 | 2018-12-04 | 北京万全德众医药生物技术有限公司 | 含有氨磺必利树脂酸盐的口服液体组合物 |
| EP3917523A4 (fr) | 2019-02-01 | 2022-10-19 | University of South Carolina | Compositions de pyridine bicyclique et procédés pour leur utilisation pour la thérapie du cancer |
| CN113209017B (zh) * | 2021-06-02 | 2023-06-20 | 上海美优制药有限公司 | 一种盐酸帕罗西汀混悬剂及其制备方法 |
| GB202212116D0 (en) | 2022-08-19 | 2022-10-05 | Beckley Psytech Ltd | Pharmaceutically acceptable salts and Compositions thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| GB9005498D0 (en) * | 1990-03-12 | 1990-05-09 | Beecham Group Plc | Composition |
| IT1246188B (it) * | 1990-07-27 | 1994-11-16 | Resa Farma | Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute. |
-
1994
- 1994-02-03 GB GB9402029A patent/GB9402029D0/en active Pending
-
1995
- 1995-01-27 MY MYPI95000223A patent/MY113036A/en unknown
- 1995-01-30 US US08/682,799 patent/US5811436A/en not_active Expired - Lifetime
- 1995-01-30 WO PCT/EP1995/000319 patent/WO1995020964A1/fr active IP Right Grant
- 1995-01-30 ES ES95906998T patent/ES2129806T3/es not_active Expired - Lifetime
- 1995-01-30 PL PL95315679A patent/PL178331B1/pl not_active IP Right Cessation
- 1995-01-30 MX MX9603203A patent/MX9603203A/es unknown
- 1995-01-30 SK SK1004-96A patent/SK281214B6/sk unknown
- 1995-01-30 NZ NZ278891A patent/NZ278891A/en not_active IP Right Cessation
- 1995-01-30 AT AT95906998T patent/ATE178489T1/de active
- 1995-01-30 RU RU96117470/14A patent/RU2136281C1/ru not_active IP Right Cessation
- 1995-01-30 CZ CZ962293A patent/CZ285128B6/cs unknown
- 1995-01-30 DK DK95906998T patent/DK0742715T3/da active
- 1995-01-30 EP EP95906998A patent/EP0742715B1/fr not_active Expired - Lifetime
- 1995-01-30 AU AU15368/95A patent/AU682091B2/en not_active Expired
- 1995-01-30 AP APAP/P/1996/000839A patent/AP611A/en active
- 1995-01-30 CN CN95191483A patent/CN1074922C/zh not_active Expired - Fee Related
- 1995-01-30 DE DE69508924T patent/DE69508924T2/de not_active Expired - Lifetime
- 1995-01-30 RO RO96-01580A patent/RO116342B1/ro unknown
- 1995-01-30 BR BR9507055A patent/BR9507055A/pt not_active IP Right Cessation
- 1995-01-30 HU HU9602151A patent/HUT75941A/hu unknown
- 1995-01-30 JP JP52037095A patent/JP4445590B2/ja not_active Expired - Lifetime
- 1995-01-30 CA CA002182593A patent/CA2182593A1/fr not_active Abandoned
- 1995-02-01 AP APAP/P/1995/000715A patent/AP536A/en active
- 1995-02-01 ZA ZA95776A patent/ZA95776B/xx unknown
- 1995-02-01 MA MA23768A patent/MA23441A1/fr unknown
- 1995-02-01 DZ DZ950010A patent/DZ1850A1/fr active
- 1995-02-02 IL IL11252195A patent/IL112521A/xx not_active IP Right Cessation
- 1995-02-09 TW TW084101235A patent/TW436296B/zh active
-
1996
- 1996-08-01 FI FI963051A patent/FI118205B/fi not_active IP Right Cessation
- 1996-08-01 BG BG100763A patent/BG62843B1/bg unknown
- 1996-08-02 OA OA60873A patent/OA10446A/en unknown
- 1996-08-02 NO NO963244A patent/NO307954B1/no not_active IP Right Cessation
-
1998
- 1998-12-16 HK HK98113631A patent/HK1012288A1/xx not_active IP Right Cessation
-
1999
- 1999-04-30 GR GR990401213T patent/GR3030131T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DZ1850A1 (fr) | Formulation nouvelle comprenant un complexe de paroxétine et d'amberlite irp 88. | |
| BRPI9810519B1 (pt) | derivados de 4''-substituìdo-9-desoxo-9a-aza-9a-homoeritromicina a e composição farmacêutica compreendendo os mesmos. | |
| NO308131B1 (no) | Hypolipidemiske 1,4-benzotiazepin-1,1-dioksider, anvendelse derav og farmasøytisk blanding | |
| LU91437I2 (fr) | "dabigatran-etexilate et ses sels- particulièrement dabigatran-etexilate-mésilate (PRADAXA)" | |
| NZ329932A (en) | Hypolipidemic 1,4-benzothiazepine-1,1-dioxides and pharmaceutical compositions thereof | |
| MA26507A1 (fr) | Compositions pharmaceutiques d'aerosol | |
| NO953262D0 (no) | Bedring av Dupuytrens sykdom | |
| NO972451D0 (no) | 2-heterocyklyloksy og tiometyl-1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og fremgangsmåte for anvendelse derav | |
| NO981388D0 (no) | Bedring av Dupuytrens sykdom | |
| PT755386E (pt) | Derivado de benzamida composicoes contendo o referido derivado e sua utilizacao | |
| FR2618072B1 (fr) | Compositions pharmaceutiques et cosmetiques a base de pyridones et d'agents antibacteriens | |
| FR2769276B1 (fr) | Articulation d'accouplement | |
| FI973230A0 (fi) | Uusi farmaseuttinen formulaatio | |
| FR2728455B1 (fr) | Dispositif d'osteosynthese | |
| FR2744917B1 (fr) | Composition therapeutique a base d'acetaminophene | |
| ITRM940387A0 (it) | "giunto a tampone viscoelastico anidro". | |
| AU7358896A (en) | 1-{4-(4'-sulfanilyl)phenyl}urea and derivatives for the treatment of leishmaniasis | |
| KR960038660U (ko) | 브라운관의 반전이재기 | |
| KR970019393U (ko) | 브이씨알 헤드의 로타리트랜스포머 연결구조 | |
| ITMI930453A0 (it) | Composizione farmaceutica avente attivita' antiasmatica | |
| KR960024629U (ko) | 롬팩을 이용한 ibm pc 전용 게임기 | |
| KR950031507U (ko) | 기판의 핀위치 표시구조 | |
| FR2768984B1 (fr) | Sulky d'un nouveau type | |
| FI1618U1 (fi) | Spelbraede foer spelet "Tornering" | |
| UA851S (uk) | Гра "школярик" |